<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02825043</url>
  </required_header>
  <id_info>
    <org_study_id>6410</org_study_id>
    <nct_id>NCT02825043</nct_id>
  </id_info>
  <brief_title>HFNC Effect on BCSS in Patients With COPD</brief_title>
  <acronym>COPD</acronym>
  <official_title>Effect of High-Flow Nasal Cannula (HFNC) on the Breathlessness, Cough, and Sputum Scale (BCSS), in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fisher and Paykel Healthcare</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oklahoma</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to look for a correlation between the use of HFNC in
      the outpatient setting in patients with previous COPD exacerbation and the change in their
      BCSS score. The hypothesis is that home use of HFNC will lead to a reduction in BCSS score by
      1.3.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective pilot study. Targeted population include patients with COPD, non-oxygen
      dependent, with a baseline normal bicarbonate on previous lab (within 6 months of
      enrollment). Patients will be randomly selected to be part of the study sample. Recruitment
      will occur in both inpatient and outpatient settings. An email briefly explaining the
      objectives of the study will be sent to Internal Medicine residents and Pulmonary Critical
      Care fellows to help in patients' recruitment. Patients will be enrolled in the study only
      after being seen by Dr. Abdo or Dr. Allen. The study is expected to finish by the end of
      January 2017 or twelve months post IRB approval. Patients will be recruited and enrolled over
      six months, and the collected data will be analyzed six months after the last patient was
      included in the study. The study will target a study sample of 30 as detailed in the
      statistical analysis section, where patients will be their own control (3 months without HFNC
      followed by 3 months with HFNC).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decreased breathlessness, cough and sputum score.</measure>
    <time_frame>6 months</time_frame>
    <description>Patients will measure score weekly and use high flow to try to decrease score/improve symptoms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Decrease COPD exacerbations.</measure>
    <time_frame>6 months</time_frame>
    <description>Monitor COPD exacerbations.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>High Flow Nasal Cannula Participants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High Flow Nasal Cannula Participants will be their own control, they will be in study for 3 months prior to receiving equipment and then will be studied for 3 additional months on study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High-Flow Nasal Cannula</intervention_name>
    <description>This is a humidified oxygen delivery system.</description>
    <arm_group_label>High Flow Nasal Cannula Participants</arm_group_label>
    <other_name>AIRVO 2 Series Humidifier</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        One previous COPD exacerbation in last year.

        Exclusion Criteria:

        Can not be oxygen dependant PaCO2 &lt; 60
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen Allen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>OUMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karen Allen, MD</last_name>
    <phone>405-271-6173</phone>
    <email>karen-allen@ouhsc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tony Abdo, MD</last_name>
    <phone>405-271-6173</phone>
    <email>Tony-Abdo@ouhsc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Oklahoma</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Allen, MD</last_name>
      <phone>405-271-1673</phone>
      <email>karen-allen@ouhsc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tony Abdo, MD</last_name>
      <phone>405-271-1673</phone>
      <email>tony-abdo@ouhsc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Spoletini G, Alotaibi M, Blasi F, Hill NS. Heated Humidified High-Flow Nasal Oxygen in Adults: Mechanisms of Action and Clinical Implications. Chest. 2015 Jul;148(1):253-261. doi: 10.1378/chest.14-2871. Review.</citation>
    <PMID>25742321</PMID>
  </reference>
  <reference>
    <citation>Nishimura M. High-flow nasal cannula oxygen therapy in adults. J Intensive Care. 2015 Mar 31;3(1):15. doi: 10.1186/s40560-015-0084-5. eCollection 2015. Review.</citation>
    <PMID>25866645</PMID>
  </reference>
  <reference>
    <citation>Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, Prat G, Boulain T, Morawiec E, Cottereau A, Devaquet J, Nseir S, Razazi K, Mira JP, Argaud L, Chakarian JC, Ricard JD, Wittebole X, Chevalier S, Herbland A, Fartoukh M, Constantin JM, Tonnelier JM, Pierrot M, Mathonnet A, Béduneau G, Delétage-Métreau C, Richard JC, Brochard L, Robert R; FLORALI Study Group; REVA Network. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015 Jun 4;372(23):2185-96. doi: 10.1056/NEJMoa1503326. Epub 2015 May 17.</citation>
    <PMID>25981908</PMID>
  </reference>
  <reference>
    <citation>Bräunlich J, Seyfarth HJ, Wirtz H. Nasal High-flow versus non-invasive ventilation in stable hypercapnic COPD: a preliminary report. Multidiscip Respir Med. 2015 Sep 3;10(1):27. doi: 10.1186/s40248-015-0019-y. eCollection 2015.</citation>
    <PMID>26339486</PMID>
  </reference>
  <reference>
    <citation>Bräunlich J, Beyer D, Mai D, Hammerschmidt S, Seyfarth HJ, Wirtz H. Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients. Respiration. 2013;85(4):319-25. doi: 10.1159/000342027. Epub 2012 Nov 1.</citation>
    <PMID>23128844</PMID>
  </reference>
  <reference>
    <citation>Nilius G, Franke KJ, Domanski U, Rühle KH, Kirkness JP, Schneider H. Effects of nasal insufflation on arterial gas exchange and breathing pattern in patients with chronic obstructive pulmonary disease and hypercapnic respiratory failure. Adv Exp Med Biol. 2013;755:27-34.</citation>
    <PMID>22826046</PMID>
  </reference>
  <reference>
    <citation>Leidy NK, Rennard SI, Schmier J, Jones MK, Goldman M. The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation. Chest. 2003 Dec;124(6):2182-91.</citation>
    <PMID>14665499</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2016</study_first_submitted>
  <study_first_submitted_qc>July 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2016</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Oklahoma</investigator_affiliation>
    <investigator_full_name>Karen Allen</investigator_full_name>
    <investigator_title>Faculty</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Will share data as a cohort for other investigators, but will not share individual participant data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

